Novavax (NVAX) Crumbles: Stock Tumbles by 7.7% - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP), Gilead Sciences (NASDAQ:GILD)

Novavax, Inc. NVAX saw a big move last session, as the company's shares fell by nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $3.97–$5.13 in the past one-month time frame, showed a sharp decline yesterday at $4.17.

Although this slump was obviously disappointing, the clinical-stage biopharmaceutical company has seen 1 positive revision and its current year loss consensus has narrowed down over the past few weeks. This suggests that the recent slump might be a temporary blip on the radar for NVAX. So make sure to keep an eye on this stock going forward to see if yesterday's price decline is confirmed by more weakness, or if it can rebound in the weeks ahead.

NVAX currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Biomed industry include Gilead Sciences Inc. GILD, ANI Pharmaceuticals, Inc. ANIP and Illumina Inc. ILMN. All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

NOVAVAX INC NVAX: Free Stock Analysis Report

GILEAD SCIENCES GILD: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

ILLUMINA INC ILMN: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs